News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
685,618 Results
Type
Article (39075)
Company Profile (280)
Press Release (646263)
Section
Business (203881)
Career Advice (1991)
Deals (35365)
Drug Delivery (85)
Drug Development (80799)
Employer Resources (168)
FDA (16086)
Job Trends (14808)
News (344563)
Policy (32437)
Tag
Academia (2531)
Alliances (49088)
Alzheimer's disease (1229)
Approvals (16018)
Artificial intelligence (130)
Bankruptcy (352)
Best Places to Work (11537)
Biotechnology (201)
Breast cancer (120)
Cancer (1081)
Cardiovascular disease (97)
Career advice (1660)
Cell therapy (232)
Clinical research (64240)
Collaboration (387)
Compensation (197)
COVID-19 (2530)
C-suite (94)
Data (1119)
Diabetes (152)
Diagnostics (6139)
Earnings (84817)
Employer resources (146)
Events (109472)
Executive appointments (310)
FDA (16621)
Funding (349)
Gene therapy (177)
GLP-1 (575)
Government (4325)
Healthcare (18670)
Infectious disease (2615)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16298)
Job creations (3625)
Job search strategy (1417)
Layoffs (412)
Legal (7854)
Lung cancer (170)
Manufacturing (176)
Medical device (13175)
Medtech (13180)
Mergers & acquisitions (19142)
Metabolic disorders (401)
Neuroscience (1504)
NextGen Class of 2024 (6500)
Non-profit (4464)
Northern California (1476)
Obesity (231)
Opinion (179)
Patents (102)
People (56282)
Phase I (19951)
Phase II (28299)
Phase III (21095)
Pipeline (455)
Postmarket research (2553)
Preclinical (8492)
Radiopharmaceuticals (236)
Rare diseases (218)
Real estate (5891)
Regulatory (21517)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1298)
Startups (3563)
United States (13447)
Vaccines (548)
Weight loss (167)
Date
Today (130)
Last 7 days (759)
Last 30 days (3778)
Last 365 days (35622)
2024 (32679)
2023 (40075)
2022 (51173)
2021 (55715)
2020 (54089)
2019 (46544)
2018 (35027)
2017 (32115)
2016 (31491)
2015 (37558)
2014 (31319)
2013 (26346)
2012 (28571)
2011 (29264)
2010 (27329)
Location
Africa (713)
Arizona (192)
Asia (37118)
Australia (6058)
California (3319)
Canada (1289)
China (247)
Colorado (144)
Connecticut (152)
Europe (79505)
Florida (458)
Georgia (116)
Illinois (341)
Indiana (196)
Kansas (96)
Maryland (575)
Massachusetts (2603)
Michigan (157)
Minnesota (272)
New Jersey (952)
New York (957)
North Carolina (701)
Northern California (1476)
Ohio (139)
Pennsylvania (843)
South America (1091)
Southern California (1298)
Texas (461)
Utah (90)
Washington State (360)
685,618 Results for "23andme inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
23andMe Cuts Headcount by 40%, Drops Drug Discovery Work
In line with the restructuring initiative, 23andMe is looking for strategic opportunities for its pipeline assets, including licensing deals or outright sales.
November 12, 2024
·
2 min read
·
Tristan Manalac
Biotech Bay
23andMe Launches New Genetic Report on Bipolar Disorder
23andMe Holding Co., a leading human genetics and biopharmaceutical company, released a new genetic Bipolar Disorder report for 23andMe+ Premium members, informing them if they are at higher likelihood for being diagnosed with the condition.
June 5, 2024
·
4 min read
Business
23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
23andMe Holding Co. and Nightingale Health Plc announced a strategic collaboration to pilot Nightingale Health’s clinically-validated and cost-effective blood metabolomics panel with a cohort of 23andMe members.
June 28, 2024
·
4 min read
Press Releases
23andMe Appoints Three New Independent Directors to Board
October 29, 2024
·
4 min read
Press Releases
23andMe to Report Q2 FY2025 Financial Results
November 8, 2024
·
3 min read
Press Releases
CORRECTION - 23andMe to Report Q2 FY2025 Financial Results
November 8, 2024
·
3 min read
Press Releases
23andMe Announces Mathew Knowles as New Brand Ambassador
October 8, 2024
·
8 min read
Press Releases
23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future
November 12, 2024
·
6 min read
Press Releases
23andMe Announces 1-for-20 Reverse Stock Split
October 14, 2024
·
6 min read
Biotech Bay
23andMe announces CEO’s intention to pursue a potential take-private
23andMe Holding Co., a leading human genetics and biopharmaceutical company, has been made aware that Anne Wojcicki, Chief Executive Officer, Co-Founder, and Chair of the Board of Directors of 23andMe, is considering making a proposal to acquire all of the outstanding shares of 23andMe that she does not currently own, as she stated in an amendment dated April 17, 2024 to her Schedule 13D filing with the Securities and Exchange Commission.
April 18, 2024
·
3 min read
1 of 68,562
Next
